Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...

Nucleus Genomics claims to give couples a picture of their combined risk for passing down hundreds of conditions to their ...

The bankruptcy of genetic-testing company 23andMe puts millions of Americans’ genomic profiles at risk of being sold to the highest bidder — including the Chinese Communist Party. For Beijing, ...

Genome writing company Replay has raised $55 million in a seed fundraising round. Replay has a portfolio of gene writing technologies that include an algorithm for rewriting proteins, a genome writing ...

For the tens of millions of Americans affected by a rare disease, their genes often hold the key to getting the answers they desperately need; from helping them obtain an accurate diagnosis, to ...

GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, has agreed to acquire California-based genomics software company Fabric Genomics for up to $51 million. Genomics is a branch of ...

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has ...

Regeneron Pharmaceuticals Inc. REGN announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company ...

If you have ever welcomed a new baby into the world, you know the mix of hope and uncertainty that comes with those first days. For decades, newborn screening has been a quiet triumph of public health ...

Transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, the leading life science-focused SPAC, led ...

Metropolis Healthcare has launched a Centre for Genomics to expand its specialty diagnostics business. The company plans to ...